Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(21):1590-1592; doi:10.1093/jnci/93.21.1590
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Reynolds, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reynolds, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 21, 1590-1592, November 7, 2001
© 2001 Oxford University Press

NEWS

Industry-Funded Versus Publicly Funded Trials: Are the Standards the Same?

Tom Reynolds

The rise of randomized controlled trials as the gold standard for answering important clinical questions tops many lists of key advances in scientific medicine during the past half century.

In recent years, along with rapid growth in the number of trials testing new drugs or new uses for existing drugs, a major shift has occurred in how these trials are funded and carried out. Twenty years ago, most trials in the United States were supported by the National Institutes of Health and conducted at academic medical centers.

Now, the majority of trials are paid for by the drug’s manufacturer. Trials can involve a hundred or more centers and thousands of patients. They are carried out in academic medical centers, public and private hospitals, and private physician practices. How has this shift and industry’s increased involvement in it affected the clinical trials system?

Many clinical trials today are conducted or managed . . . [Full Text of this Article]

Too Many Trials?

Bias in Publications

No One Immune

Networks For Research


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?